Doxorubicin and cyclophosphamide as neoadjuvant therapy. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy4

Esophagogastric Junction Cell Line, Tumor Axilla Tumor Cells, Cultured

Diseases40

Breast Neoplasms Rectal Neoplasms Esophageal Neoplasms Adenocarcinoma Sarcoma Neoplasm Recurrence, Local Pancreatic Neoplasms Lymphatic Metastasis Neoplasm, Residual Soft Tissue Neoplasms Carcinoma, Squamous Cell Neoplasm Metastasis Leukopenia Lung Neoplasms Carcinoma Carcinoma, Pancreatic Ductal Osteosarcoma Lymphoma, Non-Hodgkin Neutropenia Bone Neoplasms Carcinoma, Ductal, Breast Muscle Neoplasms Recurrence Carcinoma, Lobular Urinary Bladder Neoplasms Cystitis Nausea Ovarian Neoplasms Lymphoma, Large B-Cell, Diffuse Vomiting Thrombocytopenia Carcinoma, Small Cell Wegener Granulomatosis Leukemia P388 Lupus Nephritis Disease Progression Neoplasms Liver Neoplasms Multiple Myeloma Hematologic Diseases

Chemicals and Drugs67

Cyclophosphamide Doxorubicin Fluorouracil Epirubicin Antibiotics, Antineoplastic Antineoplastic Agents Vincristine Taxoids Cisplatin Paclitaxel Antineoplastic Agents, Alkylating Prednisone Phosphoramide Mustards Receptor, erbB-2 Methotrexate Antibodies, Monoclonal, Humanized Deoxycytidine Etoposide Anthracyclines Antineoplastic Agents, Hormonal Fluorodeoxyglucose F18 Vinblastine Ifosfamide Receptors, Estrogen Tumor Markers, Biological Organoplatinum Compounds Immunosuppressive Agents Antibodies, Monoclonal Leucovorin Radiopharmaceuticals Razoxane Granulocyte Colony-Stimulating Factor Antibodies, Monoclonal, Murine-Derived Prednisolone Mitoxantrone Bleomycin Thiotepa Carboplatin Busulfan Biomarkers, Pharmacological Mesna Antineoplastic Agents, Phytogenic Bridged Compounds Vidarabine P-Glycoprotein Receptors, Progesterone Melphalan Procarbazine Liposomes Carmustine Methylprednisolone Drug Carriers Ki-67 Antigen Chlorambucil Nitriles Dexamethasone Daunorubicin Azathioprine Tamoxifen Cytarabine Antimetabolites, Antineoplastic Polyethylene Glycols Mitomycin Dacarbazine Prodrugs Mechlorethamine Androgen Antagonists

Analytical, Diagnostic and Therapeutic Techniques and Equipment53

Neoadjuvant Therapy Chemotherapy, Adjuvant Antineoplastic Combined Chemotherapy Protocols Esophagectomy Treatment Outcome Combined Modality Therapy Chemoradiotherapy, Adjuvant Radiotherapy, Adjuvant Neoplasm Staging Disease-Free Survival Prognosis Survival Rate Survival Analysis Drug Administration Schedule Chemoradiotherapy Retrospective Studies Follow-Up Studies Prospective Studies Pancreaticoduodenectomy Pancreatectomy Nomograms Remission Induction Positron-Emission Tomography Kaplan-Meier Estimate Tumor Burden Predictive Value of Tests Tomography, X-Ray Computed Preoperative Care Mastectomy, Segmental Pulse Therapy, Drug Prostatectomy Multivariate Analysis Infusions, Intravenous Immunohistochemistry Cystectomy Bone Marrow Transplantation Transplantation, Autologous Mastectomy Clinical Trials as Topic Hematopoietic Stem Cell Transplantation Drug Therapy, Combination Whole-Body Irradiation Administration, Metronomic Drug Carriers Risk Factors Feasibility Studies Radiotherapy Dosage Neoplasm Transplantation Transplantation Conditioning Salvage Therapy Immunosuppression Pilot Projects Lymph Node Excision

Phenomena and Processes9

Time Factors Nomograms Dose-Response Relationship, Drug Drug Resistance, Neoplasm Drug Synergism Drug Resistance, Multiple Drug Resistance Apoptosis Cell Survival

Disciplines and Occupations1

Immunohistochemistry

Technology, Industry, Agriculture2

Liposomes Polyethylene Glycols

Information Science1

Health Care16

Treatment Outcome Disease-Free Survival Survival Rate Survival Analysis Retrospective Studies Follow-Up Studies Prospective Studies Nomograms Kaplan-Meier Estimate Predictive Value of Tests Preoperative Care Multivariate Analysis Clinical Trials as Topic Risk Factors Feasibility Studies Pilot Projects

Anatomy Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Technology, Industry, Agriculture Information Science Health Care

Neoadjuvant Therapy Cyclophosphamide Doxorubicin Chemotherapy, Adjuvant Antineoplastic Combined Chemotherapy Protocols Esophagectomy Breast Neoplasms Treatment Outcome Combined Modality Therapy Chemoradiotherapy, Adjuvant Radiotherapy, Adjuvant Rectal Neoplasms Fluorouracil Neoplasm Staging Epirubicin Antibiotics, Antineoplastic Disease-Free Survival Antineoplastic Agents Vincristine Taxoids Esophageal Neoplasms Cisplatin Adenocarcinoma Prognosis Survival Rate Survival Analysis Sarcoma Drug Administration Schedule Chemoradiotherapy Paclitaxel Antineoplastic Agents, Alkylating Neoplasm Recurrence, Local Prednisone Phosphoramide Mustards Receptor, erbB-2 Methotrexate Retrospective Studies Antibodies, Monoclonal, Humanized Deoxycytidine Pancreatic Neoplasms Lymphatic Metastasis Etoposide Follow-Up Studies Anthracyclines Neoplasm, Residual Prospective Studies Pancreaticoduodenectomy Antineoplastic Agents, Hormonal Pancreatectomy Time Factors Nomograms Remission Induction Positron-Emission Tomography Kaplan-Meier Estimate Fluorodeoxyglucose F18 Tumor Burden Vinblastine Ifosfamide Receptors, Estrogen Predictive Value of Tests Tumor Markers, Biological Soft Tissue Neoplasms Organoplatinum Compounds Tomography, X-Ray Computed Preoperative Care Carcinoma, Squamous Cell Immunosuppressive Agents Mastectomy, Segmental Dose-Response Relationship, Drug Neoplasm Metastasis Esophagogastric Junction Antibodies, Monoclonal Leucovorin Pulse Therapy, Drug Leukopenia Radiopharmaceuticals Razoxane Drug Resistance, Neoplasm Granulocyte Colony-Stimulating Factor Lung Neoplasms Carcinoma Antibodies, Monoclonal, Murine-Derived Carcinoma, Pancreatic Ductal Prednisolone Prostatectomy Mitoxantrone Bleomycin Osteosarcoma Thiotepa Carboplatin Lymphoma, Non-Hodgkin Busulfan Multivariate Analysis Infusions, Intravenous Immunohistochemistry Cystectomy Neutropenia Biomarkers, Pharmacological Mesna Bone Neoplasms

No FAQ available that match "doxorubicin and cyclophosphamide as neoadjuvant therapy"